References
- Maas AIR, Menon DK, Adelson PD, et al. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 2017;16(12):987–1048.
- Feigin VL, Theadom A, Barker-Collo S, et al. Incidence of traumatic brain injury in New Zealand: a population-based study. Lancet Neurol. 2013;12(1):53–64.
- Zoerle T, Carbonara M, Zanier ER, et al. Rethinking neuroprotection in severe traumatic brain injury: toward bedside neuroprotection. Front Neurol. 2017;24(8):354.
- Bleck TP. Historical aspects of critical care and the nervous system. Crit Care Clin. 2009;25(1):153–164, ix.
- Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80(1):6–15.
- London PS. Some observations on the course of events after severe injury of the head. Hunterian lecture delivered at the Royal College of Surgeons of England on 12th January 1967. Ann R Coll Surg Engl. 1967;41:460–479.
- Cifu DX, Keyser-Marcus L, Lopez E, et al. Acute predictors of successful return to work 1 year after traumatic brain injury: a multicenter analysis. Arch Phys Med Rehabil. 1997;78(2):125–131.
- Jourdan C, Azouvi P, Genêt F, et al. Disability and health consequences of traumatic brain injury: national prevalence. Am J Phys Med Rehabil. 2018;97(5):323–331.
- Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil. 2006;21(5):375–378.
- Polinder S, Haagsma JA, van Klaveren D, et al. Health-related quality of life after TBI: a systematic review of study design, instruments, measurement properties, and outcome. Popul Health Metr. 2015;13:4.
- Lee SY, Amatya B, Judson R, et al. Clinical practice guidelines for rehabilitation in traumatic brain injury: a critical appraisal. Brain Inj. 2019;33(10):1263–1271.
- Yasuhara T, Kawauchi S, Kin K, et al. Cell therapy for central nervous system disorders: current obstacles to progress. CNS Neurosci Ther. 2020;26(6):595–602.
- Gennai S, Monsel A, Hao Q, et al. Cell-based therapy for traumatic brain injury. Br J Anaesth. 2015;115(2):203–212.
- Kawabori M, Shichinohe H, Kuroda S, et al. Clinical trials of stem cell therapy for cerebral ischemic stroke. IJMS. 2020;21(19):7380.
- Cox CS Jr., Baumgartner JE, Harting MT, et al. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery. 2011;68(3):588–600.
- Liao GP, Harting MT, Hetz RA, et al. Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children. Pediatr Crit Care Med. 2015;16(3):245–255.
- Cox CS Jr., Hetz RA, Liao GP, et al. Treatment of severe adult traumatic brain injury using bone marrow mononuclear cells. Stem Cells. 2017;35(4):1065–1079.
- Zhang ZX, Guan LX, Zhang K, et al. A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury. Cytotherapy. 2008;10(2):134–139.
- Tian C, Wang X, Wang X, et al. Autologous bone marrow mesenchymal stem cell therapy in the subacute stage of traumatic brain injury by lumbar puncture. Exp Clin Transplant. 2013;11(2):176–181.
- Seledtsov VI, Rabinovich SS, Parlyuk OV, et al. Cell transplantation therapy in re-animating severely head-injured patients. Biomed Pharmacother. 2005;59(7):415–420.
- Cellvation, Inc. About us [Internet] [cited 2021 Dec 8]. Available from: https://cellvation.com/about-us/
- Cellvation, Inc. Press releases [Internet] [cited 2021 Dec 8]. Available from: https://cellvation.com/fortress-biotech-announces-cellvations-ceva101-granted-fda-regenerative-medicine-advanced-therapy-designation-for-the-treatment-of-traumatic-brain-injury/
- Sharma A, Sane H, Kulkarni P, et al. Cell therapy attempted as a novel approach for chronic traumatic brain injury – a pilot study. SpringerPlus. 2015;4:26.
- Sharma AK, Sane HM, Kulkarni PP, et al. Autologous bone marrow mononuclear cell transplantation in patients with chronic traumatic brain injury – a clinical study. Cell Regen. 2020;9(1):3.
- Wang S, Cheng H, Dai G, et al. Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury. Brain Res. 2013;1532:76–84.
- Kawabori M, Weintraub AH, Imai H, et al. Cell therapy for chronic TBI: interim analysis of the randomized controlled STEMTRA trial. Neurology. 2021;96(8):e1202–e1214.
- Fugl-Meyer AR, Jääskö L, Leyman I, et al. The post-stroke hemiplegic patient. 1. A method for evaluation of physical performance. Scand J Rehabil Med. 1975;7(1):13–31.
- See J, Dodakian L, Chou C, et al. A standardized approach to the Fugl-Meyer assessment and its implications for clinical trials. Neurorehabil Neural Repair. 2013;27(8):732–741.
- Gladstone DJ, Danells CJ, Black SE. The Fugl-Meyer assessment of motor recovery after stroke: a critical review of its measurement properties. Neurorehabil Neural Repair. 2002;16(3):232–240.
- Shirley Ryan A. Rehabilitation measures database: functional independence measure [Internet] [cited 2021 Nov 2]. Available from: https://www.sralab.org/rehabilitation-measures/fimr-instrument-fim-fimr-trademark-uniform-data-system-fro-medical
- Granger CV, Hamilton BB, Keith RA, et al. Advances in functional assessment for medical rehabilitation. Top Geriatr Rehabil. 1986;1:59–74.
- Steinberg GK, Kondziolka D, Wechsler LR, et al. Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1/2a study. J Neurosurg. 2018;1:1–11.
- Kondziolka D, Steinberg GK, Wechsler L, et al. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg. 2005;103(1):38–45.
- SanBio, Inc. News [Internet] [cited 2021 Dec 8]. Available from: https://www.sanbio.com/wp/wp-content/uploads/2020/10/20190919_SanBio-Granted-Regenerative-Medicine-Advanced-Therapy-Designation-from-the-U.S.-FDA-for-SB623_v4.pdf